Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids.

作者: Robert A. McNutt , Gary S. Ferenchick , Philip C. Kirlin , Nancy J. Hamlin

DOI: 10.1016/0002-9149(88)91390-2

关键词: Creatine kinaseCholesterolInternal medicineAnabolic steroidMyocardial infarctionMedicineAnabolismCardiologyLow-density lipoproteinHigh-density lipoproteinChest pain

摘要: A major concern facing the medical profession in dealing with athletes is widespread use of anabolic steroids despite no proof their effectiveness on athletic prowess.* Elevated circulating levels low density lipoprotein (LDL) cholesterol and lowered high (HDL) have recently been reported powerlifters using steroids.2 Therefore, steroid resultant unfavorable lipid profiles may increase risk cardiovascular disease. We report a case world class powerlifter who presented acute myocardial infarction, marked hypercholesterolemia an abnormal LDL/HDL ratio. The clinical circumstances suggest causal relationship to use. 22-year-old, 330~pound male, power weightlifter past or family history cardiac diseases was admitted severe chest pain that awakened him from sleep. patient intramuscular oral androgenic daily during 6 weeks before he developed pain. He denied cocaine Physical findings admission were normal. Laboratory studies revealed elevated creatine kinase (6,182 U/ml 15% MB band). electrocardiogram disclosed ST-segment elevations Q waves leads II, III, aVF, Vs V6. Cardiac catheterization performed 10 days after infarct demonstrated normal coronary arteries apical dyskinesia. Total serum at 596 mg/dl (LDL 513 HDL 14 mg/dl). Twenty-four

参考文章(10)
G Schonfeld, W Patsch, L L Rudel, C Nelson, M Epstein, R E Olson, Effects of dietary cholesterol and fatty acids on plasma lipoproteins. Journal of Clinical Investigation. ,vol. 69, pp. 1072- 1080 ,(1982) , 10.1172/JCI110542
Hugh McA. Taggart, Deborah Applebaum-Bowden, Steven Haffner, G.Russell Warnick, Marian C. Cheung, John J. Albers, Charles H. Chestnut, William R. Hazzard, Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis Metabolism. ,vol. 31, pp. 1147- 1152 ,(1982) , 10.1016/0026-0495(82)90166-4
C Rosendorff, J I Hoffman, E D Verrier, J Rouleau, L E Boerboom, Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circulation Research. ,vol. 48, pp. 320- 329 ,(1981) , 10.1161/01.RES.48.3.320
JOHN T. SHEPHERD, PAUL M. VANHOUTTE, Spasm of the Coronary Arteries: Causes and Consequences (the Scientist's Viewpoint) Mayo Clinic Proceedings. ,vol. 60, pp. 33- 46 ,(1985) , 10.1016/S0025-6196(12)65280-X
Ben F Hurley, Douglas R Seals, James M Hagberg, Ann C Goldberg, Steve M Ostrove, John O Holloszy, Walter G Wiest, Andrew P Goldberg, High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. JAMA. ,vol. 252, pp. 507- 513 ,(1984) , 10.1001/JAMA.1984.03350040037019
Pirjo Pietinen, Jussi K Huttunen, Dietary determinants of plasma high-density lipoprotein cholesterol American Heart Journal. ,vol. 113, pp. 620- 625 ,(1987) , 10.1016/0002-8703(87)90643-0
V. Legrand, M. Deliege, L. Henrard, J. Boland, H. Kulbertus, Patients with Myocardial Infarction and Normal Coronary Arteriogram Chest. ,vol. 82, pp. 678- 685 ,(1982) , 10.1378/CHEST.82.6.678
Percy Ec, Ergogenic aids in athletics. Medicine and science in sports. ,vol. 10, pp. 298- 303 ,(1978)
Shattil Sj, Cooper Ra, Bennett Js, Colman Rw, Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia. Journal of Laboratory and Clinical Medicine. ,vol. 89, pp. 341- ,(1977)